Form 4 for NGVT Ingevity Corp
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001567619-23-004173 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-02-28 | NGVT | Hulme Steven Paul | SVP, Pres, Perf Chem, EP | F - Tax | $82.56 | -98 | 501 | -16% | -$8,091 | |
| 2023-03-02 | 2023-02-28 | NGVT | Hulme Steven Paul | SVP, Pres, Perf Chem, EP | A - Grant | $0.00 | +970 | 1,471 | +194% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | F | D | 98 | $82.56 | 501 | D | — | — | (F1) Shares withheld by the Company to satisfy tax withholding obligations related to the 2022 RSUs that vested on February 28, 2023. |
| 2 | Common | Common Stock | 2023-02-28 | A | A | 970 | $0.00 | 1,471 | D | — | — | (F2) Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2024, 2025, and 2026. |